“According to a new report published by Introspective Market Research, Animal Model Market by Type, Application, and End User, The Global Animal Model Market Size Was Valued at USD 2.87 Billion in 2023 and is Projected to Reach USD 4.11 Billion by 2032, Growing at a CAGR of 8.6% from 2024 to 2032.”
The Animal Model Market plays a critical role in biomedical research, pharmaceutical development, and disease diagnosis by enabling scientists to study biological processes and disease progression in controlled environments. Animal models are extensively used in drug discovery, toxicology testing, and preclinical research to ensure the safety and efficacy of new therapeutics before clinical trials.
These models offer significant advantages over alternative testing methods by closely replicating human physiological and genetic conditions. Widely adopted across pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and academic institutes, animal models are indispensable in advancing medical innovations. Rising investments in life sciences research and increasing focus on personalized medicine continue to strengthen the market outlook.
Market Segmentation
The Animal Model Market is segmented into Type, Application, and End User.
By Type, the market is categorized into Mice, Rats, Zebrafish, and Others.
By Application, the market is categorized into Drug Discovery & Development, Disease Research, Toxicology Testing, and Others.
By End User, the market is categorized into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations (CROs).
Growth Driver
One of the primary growth drivers of the Animal Model Market is the increasing prevalence of chronic and genetic diseases worldwide. Rising incidences of cancer, cardiovascular disorders, neurological diseases, and metabolic conditions have intensified the demand for reliable preclinical testing models. Animal models allow researchers to evaluate disease mechanisms and therapeutic responses accurately, accelerating drug development timelines. Additionally, continuous advancements in genetic engineering and transgenic animal models have further enhanced research precision, fueling market growth.
Market Opportunity
A significant market opportunity lies in the expanding adoption of genetically modified and humanized animal models. These advanced models provide improved translational relevance by closely mimicking human disease conditions. Growing funding for genomics and precision medicine research, along with increasing collaborations between research institutes and biotechnology companies, is expected to create lucrative opportunities. Emerging economies investing in healthcare R&D infrastructure further strengthen the future growth potential of the market
Detailed Segmentation
The Animal Model Market is segmented on the basis of Type, Application, and End User.
Type
The Type segment is further classified into Mice, Rats, Zebrafish, and Others. Among these, the Mice sub-segment accounted for the highest market share in 2023. Mice models are extensively used due to their genetic similarity to humans, ease of genetic modification, and cost-effectiveness. They are widely applied in oncology, immunology, and neurological research, making them the preferred choice for preclinical studies across pharmaceutical and academic institutions.
Application
The Application segment is further classified into Drug Discovery & Development, Disease Research, and Toxicology Testing . Among these, the Drug Discovery & Development sub-segment accounted for the highest market share in 2023. This dominance is attributed to the growing number of pharmaceutical pipelines and the increasing need for preclinical validation to ensure drug safety and efficacy before human trials.
Some of The Leading/Active Market Players Are-
• Charles River Laboratories (US)
• The Jackson Laboratory (US)
• Envigo (US)
• Taconic Biosciences (US)
• Janvier Labs (France)
• Crown Bioscience (US)
• Inotiv Inc. (US)
• Eurofins Scientific (Luxembourg)
• GenOway (France)
• Horizon Discovery Group (UK)
• Hera BioLabs (US)
• Trans Genic Inc. (Japan)
• Ozgene Pty Ltd (Australia)
• PolyGene Group (Switzerland)
• Cyagen Biosciences (China)
and other active players.
Key Industry Developments
News 1:
In March 2024 , a leading biotechnology company announced the expansion of its genetically engineered animal model portfolio.
This development aims to enhance research accuracy and support advanced drug discovery programs by providing highly specialized disease-specific models for pharmaceutical and academic researchers.
News 2:
In July 2023 , a major CRO entered a strategic partnership with a research institute to accelerate preclinical testing services.
The collaboration focuses on improving research efficiency, reducing development timelines, and expanding access to innovative animal model technologies.
Key Findings of the Study
• Mice models dominate the global market due to high genetic relevance
• Drug discovery & development remains the leading application segment
• North America holds the largest market share
• Rising chronic disease burden is a major growth driver
• Genetic engineering trends are reshaping market dynamics
More Info:- https://introspectivemarketresearch.com/reports/animal-model-market/
About Us
At Introspective Market Research Private Limited , we are a forward-thinking research consulting firm committed to driving growth in the Animal Model Market . With deep insights, strategic solutions, and holistic research, we empower businesses to achieve success and dominance in the global Animal Model Market industry.
? Contact Us
Introspective Market Research Pvt. Ltd.
Phone: +91-91753-37569
Email: sales@introspectivemarketresearch.com
Web: www.introspectivemarketresearch.com
